Gregg Stone

Gregg Stone

Interventional cardiologist / Cardiologist
Icahn School of Medicine, Mount Sinai Heart, NY - New York City, United States of America

Latest contributions

OCT vs. IVUS vs. angiography guidance: a real-time updated network meta-analysis

27 Aug 2023

Ali Nazmi Calik interviews Gregg Stone about the results of the meta-analysis which he presented during the ESC Congress 2023 in Amsterdam. It showed that intravascular imaging-guided PCI (IVUS or OCT) reduces target lesion failure, cardiac death, myocardial infarction, and revascularization compared to angiography-guided PCI.

Author

Ali Nazmi Calik

Author

Gregg Stone

Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)

18 May 2023 – From EuroPCR 2023

Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.

EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on stent technology

17 May 2023 – From EuroPCR 2023

If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...

Late breaking trials on stent technology

Is PCI enough in STEMI?

18 May 2022 – From EuroPCR 2022

With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct...

Is PCI enough in STEMI?

Kenneth M. Kent, MD, PhD (1938-2020): a eulogy

19 May 2020

Kenny Kent was very influential in setting up the new specialty of Interventional Cardiology based on well collected and adjudicated data, which paved the path for the subsequent randomized clinical trials. Without his contributions, our specialty may have been like many others in Medicine, just an...

Augusto Pichard

Author

Augusto Pichard
Dr. Martin B. Leon

Author

Martin Leon

Complex PCI in high-bleeding risk patients – a case based approach - Part 2

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session on complex PCI in high-bleeding risk patients to learn more about how to balance the risks and benefits of DAPT duration, how to evaluate and manage HBR patients indicated for coronary revascularization, and to discover the practical application of current short-term DAPT studies. 

Complex PCI in high-bleeding risk patients – a case based approach - Part 2

Reviewing the evidence and distilling the learnings on STOPDAPT 2

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to learn more about the multiple factors to consider when selecting a DAPT strategy, such as: patient risk factors, likelihood of DAPT compliance, possibility of surgery, stent selection etc., and discover how the STOPDAPT-2 trial results may impact your practice.

Reviewing the evidence and distilling the learnings on STOPDAPT 2

Left main revascularization: what you should know

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover tips & tricks regarding left main bifurcation PCI techniques, and learn more about imaging and physiologic assessment of left main coronary artery and the bifurcation.

Left main revascularization: what you should know

LIVE demonstration from National Taiwan University Hospital

04 Jul 2019 – From AICT-AsiaPCR 2019

Journey toward a tailored transcatheter therapy selection part I: from mitral to tricuspid repair

22 May 2019 – From EuroPCR 2019

Find out more about how new clinical evidence (MitraFR, COAPT) will shape the future of mitral transcatheter interventions.

Tailored transcatheter therapy selection